Michael R. Migden, MD, FAAD
SESSIONS
F065 What's New in the Management of Advanced Skin Cancer
Mar 9, 2024
•
3:30 PM - 5:30 PM
•
Room 31B
DISCLOSURES
Feldan Therapeutics – Consultant (1099 relationship)(Fees); Regeneron Pharmaceuticals, Inc. – Advisory Board(Honoraria); Replimune – Consultant (1099 relationship)(Fees); Stamford Pharmaceuticals – Consultant (1099 relationship)(Fees); Sun Pharmaceuticals – Consultant (1099 relationship)(Fees);